Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 6/20 | 0.74 |
| ▸ | FAAH | O00519 | 1/20 | 0.70 |
| ▸ | MGLL | Q99685 | 1/20 | 0.70 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.68 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.68 |
| ▸ | G6PD | P11413 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24836229 | 0.92 | FAAH (0.76) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL24836231 | 0.92 | FAAH (0.81) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL24836228 | 0.90 | FAAH (0.84) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL24690027 | 0.89 | CASP3 (0.66) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL20350783 | 0.89 | CASP3 (0.66) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL28308141 | 0.89 | CASP3 (0.66) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL9376161 | 0.89 | CASP3 (0.66) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL8070856 | 0.89 | CASP3 (0.66) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL8356552 | 0.89 | CASP3 (0.66) | CASP3FAAHMGLLKAT2AKAT2B | |
| SCHEMBL358740 | 0.89 | FAAH (0.77) | CASP3FAAHMGLLKAT2AKAT2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008788-A1 | USE OF EBSELEN OR ONE OF THE DERIVATIVES THEREOF TO TREAT MITOCHONDRIAL PATHOLOGIES OR DYSFUNCTIONS | ASSOCIATION FRANCAISE CONTRE LES MYOPATHIES (FR) | 2024-01-11 | — | — | WO | disclosed |
| EP-4265601-A2 | USE OF BENZISOSELAZOLE DERIVATIVE FOR ANTI-CORONAVIRUS AND CONTROL OF INTERSTITIAL LUNG DISEASE (ILD) RELATED TO CORONAVIRUS | Shanghai Yuanxi Medicine Corp. (CN) | 2023-10-25 | — | — | EP | disclosed |
| WO-2023279426-A1 | POLYSUBSTITUTED SELENIUM-CONTAINING CYCLOPENT(HEX)ENE FRAMEWORK DERIVATIVE AND SYNTHESIS METHOD THEREFOR | 苏州大学 | 2023-01-12 | — | — | WO | disclosed |
| WO-2023277584-A1 | COMPOSITION FOR REMOVING SENSESCENT CELLS COMPRISING SELENIUM COMPOUND AS ACTIVE INGREDIENT | (주)라이프신약 | 2023-01-05 | — | — | WO | disclosed |
| US-4350702-A | 2-SUBSTITUTED BENZISOTHIAZOLONES | BEECHAM GROUP LIMITED (GB) | 1982-09-21 | — | — | US | disclosed |
| US-4243669-A | ANTICOAGULANTS | BEECHAM GROUP LIMITED (GB) | 1981-01-06 | — | — | US | disclosed |
| US-4212872-A | ANTICOAGULANTS | BEECHAM GROUP LIMITED (GB) | 1980-07-15 | — | — | US | disclosed |
| US-4212979-A | ANTITHROMOGENIC | BEECHAM GROUP LIMITED (GB) | 1980-07-15 | — | — | US | disclosed |
| US-4113728-A | ANTICOAGULANTS | BEECHAM GROUP LIMITED (GB) | 1978-09-12 | — | — | US | disclosed |